The Trendlines Group Update October 2014

logo

Creating & Developing Companies To Improve the Human Condition

… Univ. of Haifa honors Trendlines’ founders … LapSpace completes FIM … IonMed receives CE … Nitza Kardish participates on “pioneering” panel … EdenShield appears in the media …


Steve Rhodes and Todd Dollinger of The Trendlines Group

Congratulations to Trendlines’ founders Steve Rhodes and Todd Dollinger. They will be honored for their contributions to innovation in Israel by the American Society of the University of Haifa at a gala event in Chicago on November 2. Keynote speaker:Ami Ayalon, former head of Shin Bet and former commander-in-chief of the Israeli Navy. Guest performer: David Broza. For information and tickets, contact Julie Reeder.

asuh-featured

 

We’re planning our 5th Annual Trendlines Event in Israel, our portfolio companies’ showcase and networking event. This year’s event adds poster displays and product demos. The half-day event will be held in late January in the Tel Aviv area.


News from Trendlines Medical

  • IonMed receives CE certification for its surgical incision-welding device, chitoplast solder for surgical wounds, and ISO 13485 quality management systems for medical devices.
  • Omer Schalit-Cohen, VP, Business Development, Trendlines Medical, and Assaf Livne, CEO of LapSpace Medical, will present at the upcoming SpeedMind event, You and the CIA 2014 — Corporations, Incubators and Accelerators. The full-day event will be held Sunday, November 23, at the Microsoft Ventures Accelerator Auditorium in Herzilya Pituach, Israel. For additional information, contact Anat Landa of FreeMind Consultants.

News from Trendlines Agtech

  • Nitza Kardish, CEO of Trendlines Agtech, and Shalom Nachshon, CEO of Catalyst AgTech, are panelists addressing Deep Dive: Food for 9 Billion People – Agriculture 3.0, part of the Pioneers Festival, Europe’s leading event on future technologies, science ventures, and entrepreneurship. The conference is October 29-30 in Vienna, Austria.
  • Welcome to ViAqua Therapeutics, developing drug delivery for aquaculture. Shai Einbinder is the company’s CEO.

 

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize
Contrast